國網信通(600131.SH):擬使用募集資金向各子公司增資實施募投項目
格隆匯 11 月 25日丨國網信通(600131.SH)公佈,為推進相關募投項目建設,公司擬使用募集資金向募投項目實施主體子公司進行增資,用於實施上述募投項目。此次向中電普華增資2.2億元,增資後中電普華註冊資本由8.4億元增至10.6億元;向繼遠軟件增資0.8億元,增資後繼遠軟件註冊資本由4億元增至4.8億元;向中電飛華增資1.4億元,增資後中電飛華註冊資本由20514.55萬元增至34514.55萬元;向中電啟明星增資0.9億元,增資後中電啟明星註冊資本由2億元增至2.9億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.